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Introduction
While earlier studies described the occurrence of  cardiac arrhythmias as random events, data from 
implanted devices showed strong evidence of  temporal clustering of  the cardiac arrhythmia episodes 
(1–3). A more recent study analyzed more than a million paroxysmal atrial fibrillation (AF) episodes 
(4). The authors reported 2 distinct subtypes: the staccato subtype, characterized by many, short AF 
episodes; and the legato subtype, characterized by fewer, longer episodes. About 13.0% of  that study 
population averaged 1 paroxysmal AF event every 2 hours, and 6.5% averaged at least 1 event each 
hour. The clustering of  ventricular tachycardia (VT) and ventricular fibrillation (VF) forms the basis 
of  electrical storm, which is associated with significant cardiovascular morbidity (5). Because cardiac 
BACKGROUND. Simultaneous noninvasively recorded skin sympathetic nerve activity (SKNA) 
and electrocardiogram (neuECG) can be used to estimate cardiac sympathetic tone. We tested 
the hypothesis that large and prolonged SKNA bursts are associated with temporal clustering 
arrhythmias.
METHODS. We recorded neuECG in 10 patients (69 ± 10 years old) with atrial fibrillation (AF) 
episodes and in 6 patients (50 ± 13 years old) with ventricular tachycardia (VT) or fibrillation 
(VF) episodes. Clustering was defined by an arrhythmic episode followed within 1 minute by 
spontaneous recurrences of the same arrhythmia. The neuECG signals were bandpass filtered 
between 500–1000 Hz to display SKNA.
RESULTS. There were 22 AF clusters, including 231 AF episodes from 6 patients, and 9 VT/VF 
clusters, including 99 VT/VF episodes from 3 patients. A total duration of SKNA bursts associated 
with AF was longer than that during sinus rhythm (78.9 min/hour [interquartile range (IQR) 
17.5–201.3] vs. 16.3 min/hour [IQR 14.5–18.5], P = 0.022). The burst amplitude associated with AF 
in clustering patients was significantly higher than that in nonclustering patients (1.54 μV [IQR 
1.35–1.89], n = 114, vs. 1.20 μV [IQR 1.05–1.42], n = 21, P < 0.001). The SKNA bursts associated with 
VT/VF clusters lasted 9.3 ± 3.1 minutes, with peaks that averaged 1.13 ± 0.38 μV as compared with 
0.79 ± 0.11 μV at baseline (P = 0.041).
CONCLUSION. Large and sustained sympathetic nerve activities are associated with the temporal 
clustering of AF and VT/VF.
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electrophysiology is strongly modulated by the autonomic nervous system (ANS) 
(6, 7), it is reasonable to hypothesize that ANS activation plays a major role in 
arrhythmic clustering. However, it is difficult to perform heart rate variability (HRV) 
analyses when patients have ongoing cardiac arrhythmias to test that hypothesis. 
Microneurography is a standard technique for sympathetic nerve activity (SNA) 
recording. However, because it is technically difficult to achieve stable long-term 
impalement, the SNA patterns during arrhythmia clustering remain unclear. We 
(8) recently invented a potentially new method to simultaneously record electrocar-
diogram (ECG) and skin SNA (SKNA). This potentially new method (neuECG) 
has been used to document an association between SNA and the initiation of  
tachyarrhythmias (9, 10). However, those studies did not determine the mecha-
nisms of  arrhythmia clustering. While an electrical storm is usually defined by 
the occurrence of  3 or more episodes of  arrhythmia over a 24-hour period (2, 11), 
some recurrent arrhythmias may occur within minutes of  each other and cause 
consecutive and futile implantable cardioverter-defibrillator (ICD) therapies. We 
hypothesize that sustained high-amplitude SNA discharges are responsible for the 
immediate (within 1 minute) recurrences of  cardiac arrhythmias, causing arrhyth-
mia clustering. We prospectively recorded neuECG in patients with recurrent atri-
al and ventricular arrhythmias to test that hypothesis.
Results
SKNA and Clustering of AF
The patient characteristics are shown in Table 1. We studied a total of  10 patients (average age 68.5 ± 10.1 
years old, 4 males) with clinical recurrent paroxysmal AF episodes. There were no complications associ-
ated with neuECG recording over 25.1 ± 11.6 hours. A total of  301 AF episodes (18.5 per patient [Inter-
quartile range (IQR) 4.8–44.3]) were recorded, including 145 immediate recurrence of  AF (IRAF) and 156 
non-IRAF episodes. The average duration per episode of  IRAF was longer than that of  non-IRAF (57.0 
seconds [IQR 22.0–332.0] vs. 38.5 seconds [IQR 17.0–118.5], P = 0.018).
Heightened SKNA and clustering of  AF episodes. Figure 1 shows a representative neuECG recording of  AF. 
Small bursts of  SKNA (black arrows) are seen throughout the recording. A large SKNA burst (red arrow) 
was observed immediately before AF termination (blue dotted line). After 18 seconds of  sinus rhythm, the 
AF was reinitiated (red dotted line). Because the interval between the AF onset and the prior AF episode 
was <1 minute, this second AF episode is classified as IRAF. Heightened SKNA and a premature atrial 
contraction (PAC) were noted prior to IRAF (blue arrows).
SKNA bursts and AF episodes. Figure 2 shows the relationship between SKNA bursts and the episodes 
of  spontaneous AF in the same patient as in Figure 1. The recording was 24.7 hours long. We first ana-
lyzed the average voltage of  SKNA per sample (aSKNA) in each 60-second window. We then plotted the 
histogram of  aSKNA that shows the proportion of  windows with a given amplitude (Figure 2A). There 
are 2 groups of  data; each can be fitted with a Gaussian distribution. The first Gaussian distribution rep-
resents the baseline nerve discharges, while the second Gaussian distribution represents the burst activ-
ity. We used the mean plus 3 times SD of  the first Gaussian distribution (1.0434 μV) as the threshold to 
separate these 2 groups of  activities. Figure 2B shows actual recordings at points marked by the single, 
double, and triple asterisks in Figure 2A. In Figure 2B (top), small SKNA discharges during sinus 
rhythm occurred regularly. In both the middle and bottom panels of  Figure 2B (sinus rhythm and AF, 
respectively), large SKNA firings were observed irregularly. Figure 2C shows continuous recoding over 
the same period as shown in Figure 2A. The onsets of  AF were indicated by red (IRAF) and orange 
(non-IRAF) dots. The horizontal dotted red line indicates the threshold for burst determination (1.0434 
μV). The leading edge and trailing edge of  each burst is automatically determined. Binary time series 
graph below Figure 2C shows the SKNA burst (black) versus nonbursting period (white). There are a 
total of  68 SKNA bursts in the entire recording. For identifying the threshold in 10 patients with AF, 
neuECG recordings were used over a mean of  19.7 ± 5.5 hours (Table 2). There were 14.0 AF episodes 
per patient (IQR 4.8–44.3). The lower mean of  2 Gaussian distributions was 0.8685 ± 0.1734 μV as 
the baseline, and the higher one was 1.3245 ± 0.2684 μV as the burst. The mean threshold for the burst 
Table 1. Characteristics of the patients with AF
Characteristics
Patient number 10
Age 68.5 ± 10.1
Male 4 (40)
Left ventricular ejection 
fraction, %
54.9 ± 8.4
Left atrial diameter, mm 40.1 ± 9.7
CHA2DS2-VASc score 3.6 ± 1.5
Chronic kidney disease 3 (30)
Coronary artery disease 6 (60)
Valvular disease 3 (30)
Metoprolol, 12.5–100 mg 7 (70)
Amiodarone, 200–400 mg 6 (60)
Verapamil, 120 mg 1 (10)
All values are presented as means ± SDs or n (%). AF, 
atrial fibrillation
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determination was 1.0771 ± 0.2293 μV. There were a total of  651 SKNA bursts, including 135 bursts 
associated with the onset of  AF and during AF. More SKNA bursts per recording window occurred at 
the onset of  AF and during AF than that during sinus rhythm (4.9 bursts/hour [IQR 3.4–11.4] vs. 3.2 
bursts/hour [IQR 2.7–3.8], P = 0.028). A total duration of  burst associated with AF was longer than 
that during sinus rhythm (78.9 min/hour [IQR 17.5–201.3] vs. 16.3 min/hour [IQR 14.5–18.5], P = 
0.022). The peak amplitude of  burst associated with AF was higher than that during sinus rhythm (1.48 
μV [IQR 1.30–1.83], n = 135 vs. 1.39 μV [IQR 1.21–1.64], n = 516, P = 0.001). The burst amplitude 
associated with AF positively correlated with the duration of  the burst (r = 0.694, P < 0.001), while that 
during sinus rhythm weakly correlated (r = 0.422, P < 0.001).
There were 6 patients with clustering episodes (clustering patients) and 4 patients without one (non-
clustering patients). Table 3 shows the characteristics of  SKNA bursts comparing those patients. More AF 
episodes were observed in clustering patients than that in nonclustering patients (46.7 ± 32.8/patient vs. 
3.3 ± 2.9/patient, P = 0.016; 51.3/day [IQR 27.9–68.2] vs. 3.1/day [IQR 1.2–6.8], P = 0.011). Frequency 
and duration of  SKNA bursts were not significantly different between clustering and nonclustering patients 
(Table 3). Figure 3 is the box-and-whisker plot indicating the distribution of  burst amplitude, which shows 
a significantly higher range in clustering than nonclustering patients (1.44 μV [IQR 1.29–1.71], n = 434, 
vs. 1.30 μV [IQR 1.01–1.61], n = 217, P < 0.001) (Figure 3A). Furthermore, the burst amplitude associated 
with AF in clustering patients is significantly higher than that in nonclustering patients (1.54 μV [IQR1.35–
1.89], n = 114, vs. 1.20 μV [IQR 1.05–1.42], n = 21, P < 0.001) (Figure 3B).
SKNA precedes the onset and offset of  AF. Figure 4 shows a typical example of  AF clustering. Figure 4A 
shows continuous recording in the same patient as shown in Figure 1. The initial rhythm was sinus. A large 
increase of  aSKNA is associated with sinus rate acceleration (red dot), followed by onset of  AF (first red 
dotted line). These consecutive SKNA bursts lasted 96 minutes (black bar), during which multiple episodes 
of  AF were observed. Subsequent short bursts of  SKNA were associated with sinus rate acceleration but 
Figure 1. Representative neuECG recording of an IRAF episode. These recordings were performed using standard skin 
patch electrodes. Consistent with that reported in a previous manuscript (9), large bursts of SKNA (red arrows) were 
associated with AF termination. There were 2 consecutive IRAF episodes that occurred within 60 seconds (s) of the 
prior episode of AF. Each episode was preceded by a premature atrial contribution (blue arrows). Small bursts of nerve 
activities (black arrows) were seen multiple times during the recording. The onsets of AF are indicated by red dotted 
lines, and the terminations of AF are indicated by blue dotted lines. SKNA, skin sympathetic nerve activity; iSKNA, 
integrated SKNA; AF, atrial fibrillation; ECG, electrocardiogram; HR, heart rate.
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not AF, until toward the right end of  the recording, when a larger and long (21-minute) burst of  SKNA 
resulted in AF episodes. The latency between onset of  aSKNA to first episodes of  AF was 18 minutes for 
the first and 9 minutes for the second cluster (red bars). The latency between the last peaks of  aSKNA to 
last episodes of  AF was 3 minutes for both clusters (blue bars). There were 22 AF clusters including 231 AF 
episodes (5.0/cluster [IQR 3.0–12.8]) from 6 patients studied (average 3.7 ± 1.8 per patient). In 22 clusters 
of  AF episodes, peak amplitude of  SKNA was 1.97 ± 0.58 μV, which was more than twice the baseline 
SKNA values taken before the onset of  the bursts (0.98 ± 0.33, P < 0.001). The mean duration of  nerve 
bursts associated with AF clustering were 74.0 ± 59.9 minutes. The median of  latency between large aSK-
NA to the onset of  AF cluster was 9.0 minutes (IQR 5.0–15.5). The median of  latency from the last peak of  
SKNA bursts to the last AF episode was 6.5 minutes (IQR 2.3–9.8). We performed HRV analyses in 17 AF 
clustering episodes. As shown in Table 4, there were no differences in HRV parameters in either the time or 
the frequency domain analyses. In 9 AF clustering episodes, multiple PACs preceded the onset of  clustering 
after SKNA activation. However, there were no differences in peak SKNA amplitude, burst duration, or the 
latency to the onset of  AF cluster, regardless of  the presence of  preceding PACs. The aSKNA 10 seconds 
prior to the onset of  IRAF were significantly higher than that of  non-IRAF (1.61 ± 1.04 μV vs. 1.14 ± 0.37 
μV, P < 0.001). Similarly, aSKNA 10 seconds before and after termination of  AF were both higher in IRAF 
than those of  non-IRAF (1.53 ± 0.96 μV vs. 1.14 ± 0.35 μV, P < 0.001, and 1.55 ± 0.99 μV vs. 1.16 ± 0.39 
μV, P = 0.001, respectively).
Bradycardia and IRAF. In spite of  high sympathetic tone, there was significant bradycardia prior to 
the onset of  IRAF episodes (Figure 1). The sinus heart rate (HR) before onset was significantly lower in 
IRAF than in non-IRAF episodes (69.6 ± 12.7 beats per minute [bpm] vs. 75.8 ± 11.8 bpm, P < 0.001). 
Figure 2. Representative SKNA burst in AF patient. The data came from the same patient as shown in Figure 1. (A) The proportion of aSKNA recorded 
every 60 s. The aSKNA indicated 2 Gaussian distributions. The burst threshold is indicated by a red dotted line, which was calculated as the mean repre-
senting lower amplitude plus 3 times SD. (B) Actual recordings of the SKNA in Lead I in a 30-s window. These recordings correspond to * (sinus), ** (sinus), 
and *** (AF) in A. Small SKNA discharges occurred regularly (top). Large SKNA bursts were observed irregularly (middle and bottom). (C) Heart rate (black 
line) and average SKNA (aSKNA) from Lead I (blue) plotted over time. The onsets of AF are indicated by red (IRAF) and orange (non-IRAF) dots. The large 
and frequent SKNA bursts occurred during AF. There were smaller bursts of nerve activities associated with sinus rate acceleration. Binary time series 
graph shows the SKNA burst (black) versus nonbursting period (white), indicating that SKNA bursts preceded the AF clustering episodes. SKNA, skin 
sympathetic nerve activity; AF, atrial fibrillation; HR, heart rate.
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The cumulative relative frequency distribution of  the HR before IRAF was significantly (P < 0.001) lower 
than that of  non-IRAF (Figure 5). Bradycardia 10 seconds before the onset of  AF was observed in 40 
IRAF episodes (27.6%) and 22 non-IRAF (14.1%). The odds ratio was 2.32 (95% CI, 1.30–4.14, P = 
0.004). Simultaneous sympathovagal discharges are associated with the onset of  AF in a canine model 
(12). However, we do not have vagal nerve recording to test that hypothesis.
Circadian variation of  AF. To study the circadian variation of  AF onset, 144 AF episodes including 87 
IRAF and 57 non-IRAF from 6 patients (24.0 ± 29.7 episodes/patient) with over 24 hours (24.7 hours [IQR 
24.5–27.2]) of  continuous recording were analyzed. Figure 6A shows that, for all AF episodes studied, the AF 
onset was not uniformly distributed (P < 0.004). There was a significant increase of  AF onsets in early morn-
ing as compared with other times of  the day (P < 0.00179 after Bonferroni correction). When only IRAF 
episodes were analyzed (Figure 6B), the same early morning peak was detected (P = 0.001). A total 24 IRAF 
episodes (27.5%) occurred between 6 a.m. and 9 a.m. The presence of  an early morning peak and a second 
afternoon peak in Figure 6B is similar to the circadian distribution reported for symptomatic AF episodes 
(13). In contrast, there was no significant differences in the distribution of  non-IRAF episodes (Figure 6C).
SKNA and clustering of ventricular arrhythmias
Table 5 shows the clinical characteristics of  the patients included in the study. Among a total of  119 episodes, 
84 were immediate recurrences of  VT/VF (IRVT) and 35 were non-IRVT episodes. Figure 7, A and B, show 
typical examples of  non-IRVT and IRVT episodes, respectively. There were multiple SKNA bursts before 
the onset of  all VT episodes (downward arrows). In these examples, non-IRVT was monomorphic (Figure 
7A), while IRVT was polymorphic (Figure 7B). For all episodes studied, IRVT episodes were significantly 
more likely to be polymorphic than non-IRVT episodes (odds ratio = 9.90; 95% CI, 3.79–25.83, P < 0.001).
Figure 8 shows that the clustering of  the VT episodes were associated with large and long bursts of  
SKNA in 2 different patients. Figure 8A shows a 1-hour tracing of  aSKNA in a patient with 8 episodes 
of  recurrent VT/VF. Following large elevation of  SKNA, there was initially sinus rate acceleration 
(red dot) followed by multiple episodes of  VT (red dotted lines). The latency between aSKNA onset 
and VT was 3 minutes (red bar). The latency between the last peak of  aSKNA and last episode of  VT 
was 3 minutes (blue bar). After VT clustering, the smaller aSKNA bursts failed to induce any cardiac 
arrhythmias. Figure 8B shows a 2-hour tracing of  aSKNA in a different patient with 11 recurrent VT/
VF episodes. Similar to Figure 8A, the elevation of  SKNA preceded VT episodes, and the latency 
between SKNA onset and VT were 2 minutes and 7 minutes, respectively. The aSKNA returned to 
baseline after the first cluster. The small bursts of  SKNA only resulted in sinus rate variations, while 
a larger burst of  aSKNA resulted in subsequent non-IRVT. Because HR and nerve activities were 
Table 2. Characteristics of SKNA burst in the patients with AF
P value
Duration of recording (hr)
     Entire recording 19.6 (19.0–23.7)
     AF 1.8 (0.7–2.5) 0.007
     Sinus 17.1 (12.1–19.3)
AF (episodes/patient) 14.0 (4.8–44.3)
AF frequency (episodes/day) 17.0 (5.7–54.1)
Burst frequency (bursts/hr)
     Entire recording 3.5 (2.9–3.9)
     AF 4.9 (3.4–11.4) 0.028
     Sinus 3.2 (2.7–3.8)
Duration of burst (min/hr)
     Entire recording 24.1 (14.5–34.9)
     AF 78.9 (17.5–201.3) 0.022
     Sinus 16.3 (14.5–18.5)
Peak amplitude of burst (μV)
     Entire recording (n = 651) 1.41 (1.23–1.67)
     AF (n = 135) 1.48 (1.30–1.83) 0.001
     Sinus (n = 516) 1.39 (1.21–1.64)
All values are presented as median (IQR). AF, atrial fibrillation.
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averaged over 1-minute windows that contain both sinus rhythm and VT, the HR was <100 bpm in 
these graphs. When we analyzed only the rate of  VT episodes, they were 151.5 ± 23.0 bpm (n = 11) 
for Figure 8A and 175.8 ± 6.6 bpm for Figure 8B (n = 8). Due to the temporal proximity of  IRVT epi-
sodes, not all VT onsets were represented by a red dotted line in that figure. There were 9 VT clusters 
including a total of  99 VT/VF episodes (10.0 per cluster [IQR 4.0–13.0]) from 3 patients (3.0 ± 2.0 per 
patient). The aSKNA bursts associated with VT/VF clustering had peaks that averaged 1.13 ± 0.38 μV, 
which was greater than the baseline aSKNA taken from the time prior to VT/VF onset (0.79 ± 0.11 
μV, P = 0.041). The mean burst duration associated with VT/VF clustering was 9.3 ± 3.1 minutes, 
which was significantly (P < 0.001) shorter than that of  AF clustering. The average latency between 
large aSKNA and the onset of  VT cluster was 2.7 ± 1.5 minutes, which was significantly (P = 0.001) 
shorter than between the increase of  aSKNA to the onset of  AF clustering. The latency between the 
last SKNA peak and the offset of  VT cluster (i.e., the final episode of  VT/VF) was 2.0 ± 1.3 minutes, 
which was also significantly (P = 0.010) shorter than the latency between last SKNA peak and the 
offset of  AF clusters. The IRVT episodes were more likely to occur within 1 minute of  aSKNA peak 
(81.3% ± 15.5%) than the IRAF (50.9% ± 18.1%, P = 0.025).
Table 3. SKNA bursts in patients with AF clustering episodes
Nonclustering patients (n = 4) Clustering patients (n = 6) P value
Duration of recording (hr)
    Entire recording 19.3 (17.9–20.8) 20.3 (19.1–23.7) 0.881
    AF 0.27 (0.02–1.03) 1.98 (1.75–6.73) 0.087
    Sinus 18.0 (15.8–20.8) 14.6 (11.6–18.6) 0.421
AF (episodes/patient) 3.3 ± 2.9 46.7 ± 32.8 0.016
AF frequency (episodes/day) 3.1 (1.2–6.8) 51.3 (27.9–68.2) 0.011
Burst frequency (bursts/hr) 2.9 ± 1.4 3.6 ± 0.8 0.276
Duration of burst (min/hr) 24.1 ± 16.2 23.9 ± 13.2 0.986
Peak amplitude of burst (μV) (n = 651) 1.30 (1.01–1.61) 1.44 (1.29–1.71) <0.001
All values are presented as means ± SDs or median (IQR). AF, atrial fibrillation.
 
Figure 3. Distribution of SKNA burst in the patients with clustering versus nonclustering episodes. The box-and-
whisker plots indicate the distribution of peak burst amplitude of average SKNA in a 60-s window. (A) In patients 
with clustering episodes, SKNA bursts distributed in the higher ranges than in the patients without clustering. (B) The 
distribution range associated during sinus rhythm are similar in both patients, but median amplitude are higher in 
the patients with clustering episodes. Furthermore, the distribution of bursts associated with AF in the patients with 
clustering episodes was much higher than in the patients without one. All box-and-whisker plots show medians and 
25th and 75th percentiles, and the whiskers show the minimum and maximum, excluding outlying values. Black dots 
indicate outlying values. P values shown in A and B were determined by the Mann-Whitney U test. SKNA, skin sympa-
thetic nerve activity; AF, atrial fibrillation; IQR, interquartile range.
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Discussion
A major finding of  this study is that large and sustained SKNA is associated with the temporal clustering 
of  paroxysmal AF and VT/VF episodes. These findings suggest that neuromodulation methods that inhibit 
or reduce SNA may prevent arrhythmia clustering. However, because bursts of  SKNA may also precede the 
termination of  paroxysmal AF episodes (14), it is also possible that neuromodulation may be proarrhyth-
mic in some patients.
SNA and cardiac arrhythmia. In ambulatory dogs, both extrinsic and intrinsic cardiac nerve activ-
ities frequently precede the onset of  spontaneous atrial tachycardia and AF (15–17). Ablation of  the 
stellate ganglion (SG) or the ganglionated plexi (GP) reduced or eliminated these atrial arrhythmias, 
suggesting a causal relationship between SNA and the occurrences of  AF (17–19). It is possible that SG 
ablation or block in humans might also be useful in suppression AF, which is the most common cause 
of  inappropriate shocks in patients with ICDs (20). However, because clustering of  AF does not create 
a medical emergency, it is difficult to justify an invasive and irreversible procedure to control these 
arrhythmias. On the other hand, recurrent VT/VF (electrical storm) requires immediate and intensive 
antiarrhythmic management. The most commonly used drugs include amiodarone and β blockers (21, 
22). In patients refractory to pharmacological managements, percutaneous SG block and left cardiac 
sympathetic denervation might be effective (23–25). However, we do not have data in the present study 
Figure 4. Typical examples of AF clustering. The data came from the same patient as shown in Figure 1. (A) Heart rate (black line) and average SKNA 
(aSKNA) from Lead I (blue) and Lead II (green) plotted over time. The onsets of AF are indicated by red dotted lines. Color shades indicate the duration of 
IRAF and non-IRAF episodes. Two red dots indicate the onset of SKNA, which was associated with sinus HR acceleration before the development of AF. 
There is an onset latency between SKNA to the first AF episode (red bars) and an offset latency between the last peak of aSKNA to the last AF episode 
(blue bars). The first large SKNA bursts lasted 96 minutes and the second episode lasted 21 minutes (black bars). There were smaller bursts of nerve activ-
ities associated with sinus rate acceleration (black arrows). (B) Actual recordings of the SKNA in Lead I (upper tracing) and ECG (lower tracing) in consecu-
tive 2-minute windows showing multiple episodes of IRAF. The time of these recordings correspond to the double-headed arrows in A. High aSKNA level 
continued between IRAF episodes. The SKNA level reduced to baseline at the end of the 20-minute window, and no AF was observed for the next 2 hours. 
SKNA, skin sympathetic nerve activity; AF, atrial fibrillation; HR, heart rate; ECG, electrocardiogram.
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to document a causal relationship between SKNA bursts and arrhythmia clustering. We have previously 
recorded SKNA in patients with epilepsy but no heart diseases (26). In that study, bursts of  SKNA did 
not induce AF. In contrast, out of  a total of  651 SKNA bursts in the present study, 135 were associated 
with AF. These findings suggest that SKNA bursts may be one of  the proarrhythmic influences that play 
a prominent role in some patients and their arrhythmias and less so in others.
SKNA burst detection. Taniguchi et al. (27) used unconjugated horseradish peroxidase as a tracer to 
study the source of  skin sympathetic nerves in dogs. The results show that the sympathetic postgangli-
onic fibers from the SG are distributed in the skin area between the third cervical vertebra and the level 
of  the thirteenth rib. The direct communication between the SG and the cervical/thoracic skin provided 
the physiological basis for the use of  SKNA to estimate the SG nerve activity (SGNA) in canine (28, 
29) models and in humans (8–10). A prominent characteristic of  the electrical activity in the nervous 
system is the prevalence of  spontaneous activity, both at the level of  the spatially summed potentials 
observed with a gross electrode and at the level of  the action potentials of  a single neuron (30). These 
spontaneous activities include both single-spike activity and the burst-firing mode (31). The single-spike 
Table 4. HRV parameters in patients with AF clustering episodes
Before SKNA onset (n = 17) After SKNA onset (n = 17) P value
Average RRI (ms) 912 (759–999) 932 (746–944) 0.320
SDNN (ms) 22 (18–38) 38 (9–50) 0.434
RMSSD (ms) 54 (18–73) 58 (15–79) 1.000
TP (ms2) 469 (247–1549) 1019 (140–1629) 0.435
VLF (ms2) 79 (28–197) 90 (55–251) 0.177
LF (ms2) 55 (32–94) 71 (20–106) 0.469
LF nu 23.0 (9.6–42.5) 14.6 (9.0–38.8) 0.831
HF(ms2) 348 (24–729) 320 (38–853) 0.492
HF nu 57.4 (34.9–729) 58.5 (55.7–72.6) 0.554
LF/HF ratio 0.4 (0.1–0.9) 0.2 (0.2–0.7) 0.323
All values are presented as median (IQR). HRV, heart rate variability; AF, atrial fibrillation; RRI, RR interval; SDNN, the standard deviation of normal 
to normal beat intervals; RMSSD, root mean square of successive differences; TP, total power; VLF, very low frequency; LF, low frequency; LF nu, low 
frequency normalized unit; HF, high frequency; HF nu, high frequency normalized unit.
 
Figure 5. Cumulative relative frequency of heart rate 10 s before AF onset. There was a significant (P < 0.001) 
difference between heart rate before IRAF (blue line) and that of non-IRAF (orange line). At 50% of the distribution 
(dotted line), heart rate before onset was 65 bpm in IRAF and 75 bpm in non-IRAF. The P value was determined by the 
Mann-Whitney U test based on data distribution. AF, atrial fibrillation.
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mode of  nerve activity demonstrates a variations of  activation frequencies and amplitude with Gauss-
ian distribution (30, 31). The burst mode increases the number of  nerve spikes within a unit time, 
resulting in increased amplitudes and firing frequencies. The burst discharges, therefore, should have 
a higher integrated or averaged nerve activity per unit time window than single-spike activity. Bursts 
are important physiological events but are difficult to identify because bursting activities or patterns 
vary with physiological conditions or external stimuli. One approach is to analyze the interspike inter-
val or spike frequencies and to then use mathematical calculations and statistical analyses to achieve 
burst detection (32, 33). However, a computer algorithm may not be completely reliable. Thus, manual 
analyses by blinded observers are needed to detect and count bursts (34). While it is possible to detect 
spike frequencies of  single neurons, the same may not be applicable to recordings made with gross 
electrodes. One advantage of  neuECG recording, over the microelectrode recording, is that neuECG 
recording uses equipment calibrated for voltage recording rather than using artificial amplitude units. 
Because true voltage is available for each digitized data point, it is possible to develop an amplitude 
based automated method for burst detection, as shown in Figure 2. We found that the amplitudes and 
the duration of  the bursts are both associated with the occurrences of  AF and VT. Large sustained 
SNA bursts are responsible for the generation and maintenance of  the arrhythmia clusters observed in 
this study. These findings are consistent with the clinical observation that percutaneous SG block and 
left cardiac sympathetic denervation are effective in managing patients with drug-resistant ventricular 
arrhythmias (23–25).
Staccato and the legato types of  AF. Wineinger et al. (4) recently reported that there are 2 types of  AF. 
The AF with short duration and frequent episodes were staccato type, while the ones with longer but 
less frequent episodes were the legato type. The authors posit that paroxysmal AF progresses over time 
from the staccato to the legato phenotype, where the shorter events grow longer and begin to link with 
one another to generate more sustained bouts. The patients in the present study also have 2 distinct 
phenotypes. The 6 patients with clustering episodes of  AF had the extreme staccato types of  AF, with 
an average of  51.3 episodes of  AF per day. The remaining 4 patients had much fewer episodes of  AF 
(3.1 episodes/day) but still fell within the spectrum of  staccato type of  AF. While the frequency and 
duration of  SKNA bursts were not significantly different between these 2 types of  AF, the burst ampli-
tude was much higher in clustering than nonclustering patients. These data suggest that these 2 AF 
Figure 6. The distribution of AF episodes in 3-hour bins over a 24-hour period of all patients studied. (A) The number of AF onset. There were a 
peak in early morning and another one prior to midnight. Among them, only the early morning peak had significantly (*P < 0.00179) more episodes 
than other times of the day adjusted by Bonferroni correction. (B) Similar to A, the distribution of IRAF episodes shows a significant peak in early 
morning. (C) There was no significant difference in the distribution of non-IRAF episodes at different times of the day. P values in A–C were deter-
mined by the χ2 goodness-of-fit test, and post hoc pair-wise comparison of the number of AF onset were performed by the exact binomial test with 
Bonferroni correction. AF, atrial fibrillation.
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phenotypes are determined, at least in part, by the magnitudes of  SNA and may be amenable to neuro-
modulation procedures that reduce sympathetic tone. However, we do not have data on legato type AF 
for comparison. Prolonged outpatient monitoring will be needed to detect that type of  AF.
The latency between onset and offset of  large SKNA bursts and the occurrence and termination of  cardiac 
arrhythmia clusters. We documented a significant latency between the onset and offset of  SKNA bursts and 
the occurrence and termination, respectively, of  cardiac arrhythmia clusters. These findings suggest that 
prolonged large SNA bursts measured in minutes are needed to be arrhythmogenic, and their electrophys-
iological effects continue for at least a few minutes after termination of  the bursts. A possible explanation 
for these observations is that persistent large-nerve discharges are needed for sufficient neurotransmitters 
to accumulate in the myocardium, leading to electrophysiological changes needed to induce arrhythmia. 
Similarly, after the large burst subsides, time is needed for those transmitters to be removed from the myo-
cardium. Before they are removed, the patients are at risk for further arrhythmia episodes. In normal dogs, 
the myocardial norepinephrine (NE) concentration is over 1000 ng/g of  the ventricular tissue, while the 
plasma NE is only around 200 pg/ml (35). Heart failure massively increases plasma NE but reduces the 
myocardial NE concentration due to loss of  nerve terminals (35) and/or a posttranscriptional downregu-
lation of  NE transporter per neuron (36). The VT/VF patients in the present study had low left ventricular 
ejection fraction and heart failure. The reduced nerve terminal and inefficient NE uptake might partially 
explain the mechanisms of  short latency between onset of  SKNA and VT/VF clustering. In contrast, the 
latency is longer in patients with AF, who mostly do not have heart failure. In addition to NE accumula-
tion, patients with heart failure are prone to arrhythmogenic ion channel remodeling (37). That remodel-
ing process could also account for a shorter latency in VT/VF than in AF.
Table 5. Characteristics of the patients with electrical storm
Characteristic
Patient number 6
Age 49.7 ± 13.2
Male 4 (67)
Criteria met for electrical storm
     ≥3 ICD therapies 4 (67)
     ≥3 Sustained VT/VF 2 (33)
Nature of presenting arrhythmias
     Monomorphic VT 5 (83)
     Polymorphic VT 5 (83)
     VF 3 (50)
ICD at enrollment or within 6 months of enrollment 5 (83)
ICD indication 3 (60)
     Primary prevention 2 (40)
     Secondary prevention
Ischemic cardiomyopathy 4 (67)
Nonischemic cardiomyopathy 3 (50)
Left ventricular ejection fraction 29.8 ± 10.1
NYHA Class 3.2 ± 1.0
Diabetes 2 (33)
Hypertension 4 (67)
CKD ≥Stage III 1 (17)
AF 1 (17)
Amiodarone i.v. infusion 5 (83)
Metoprolol, 25–75 mg 2 (33)
Carvedilol, 12.5 mg 2 (33)
Flecainide, 300 mg 1 (17)
Verapamil, 120 mg 1 (17)
All values are presented as means ± SDs or n (%). ICD, implantable cardioverter-defibrillator; NYHA, New York Heart 
Association; CKD, chronic kidney disease; AF, atrial fibrillation; VT, ventricular tachycardia; VF, ventricular fibrillation. 
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Differences of  IRAF and IRVT. Our data show that it is less likely for IRAF to be associated with aSKNA 
peak than IRVT. The weak relationship of  IRAF and the peak of  aSKNA suggest that, in addition to sym-
pathetic tone, the parasympathetic nerve activity may also play a role in triggering AF. Consistent with the 
latter hypothesis, we found a high probability of  sinus bradycardia prior to the onset of  AF. However, we 
did not perform direct parasympathetic nerve recording to test that hypothesis.
HRV. An alternative method for noninvasive determination of  autonomic tone is the HRV analyses. 
However, both AF and heart failure can be associated with significant sinoatrial node dysfunction (38, 
39). Because sinoatrial node response to autonomic tone may be compromised, the HRV parameters may 
not reflect the true autonomic tone. We (40) have previously determined HRV parameters in ambulatory 
dogs with myocardial infarction. The results show that s.c. nerve activity is more accurate than HRV in 
estimating SGNA in those dogs. Because almost all of  our patients had either AF or heart failure, it is not 
surprising that HRV analyses failed to detect the elevated sympathetic tone immediately prior to the onset 
of  AF clustering episodes.
Limitations of  the study. The data were obtained while the patients were being managed for their arrhyth-
mias. It is unclear if  the antiarrhythmic medications have affected the SKNA patterns.
Conclusion. We conclude that large and sustained SKNA bursts underlie the mechanisms of  clustering 
of  cardiac arrhythmias.
Methods
Study population
We reviewed the live telemetry recording of  the inpatients to prospectively identify patients with a history 
of  paroxysmal AF for recording. Patients were treated at IU Health Methodist Hospital, Indianapolis, Indi-
ana, USA. Among a total of  13 patients recorded, 10 had paroxysmal AF during neuECG recording and 
were included in the analyses. The data from 8 of  the 10 patients were used in a previous report (9). We also 
Figure 7. Relationship between SKNA and VT. (A) Actual recording of the SKNA in Lead I and ECG in the patient with single VT episode. The onsets 
of VT are indicated by red dotted lines, and the terminations of VT are indicated by blue dotted lines. SKNA discharges (downward arrows) were 
observed before VT onset. (B) Actual recording in the patient with early recurrence of VT episodes. Multiple SKNA bursts occurred during sinus 
rhythm between VT episodes and also during VT. SKNA, skin sympathetic nerve activity; iSKNA, integrated SKNA; VT, ventricular tachycardia; ECG, 
electrocardiogram; HR, heart rate.
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recorded neuECG from 23 patients admitted to the hospital with 3 or more recurrent ventricular tachyar-
rhythmias over a 24-hour period (electrical storm). Because of  medical therapy, only 10 of  the 23 patients 
had documented VT/VF during the recording period. Among them, 6 had clean neuECG recordings and 
were included in a previous report (10). The data of  the same 6 patients were reanalyzed in this study.
Data analysis
Average SKNA amplitude. We used a modified portable ME6000 Biomonitor (Mega Electronics Ltd.) for 
data acquisition. Taniguchi et al. (27) showed that sympathetic postganglionic cells of  the SG in dogs 
project to the skin in the cervical, forelimb, and thoracic regions. Therefore, all patients had ECG Lead I 
recorded with 1 electrode in the right subclavian area and the other electrode in the left subclavian area. A 
second channel was used to record SKNA from the left arm in patients with AF (9). In patients with VT/
VF, the second channel was the ECG Lead II, with 1 electrode located at right subclavian area and the oth-
er in the left lower abdomen (8). We analyzed recordings from all channels using custom-written software. 
The neuECG signals were amplified and bandpass filtered between 0.5 Hz and 150 Hz to display ECG and 
between 500 Hz and 1000 Hz to show the SKNA. We full-wave rectified and integrated all digitized SKNA 
signals every 100 ms and displayed the results over time to simulate the display methods of  microneurogra-
phy (41). Furthermore, we divided the total voltage by the number of  digitized samples in the same window 
to obtain the aSKNA (8). The aSKNA was plotted over time to identify the peak of  aSKNA, defined by the 
time point bracketed by >10-second crescendo and >10-second decrescendo of  aSKNA values (10).
Burst analyses. A prominent characteristic of  the electrical activity in the nervous system is the 
prevalence of  spontaneous activities that include both single-spike activity and the burst-firing mode 
(31). The single-spike mode of  baseline nerve activity demonstrate variations of  activation frequencies 
and amplitude with Gaussian distribution (30, 31). The burst activity can be distinguished from the 
Figure 8. Clustering of VT episodes. (A) The data came from same patient as shown in Figure 6B. Heart rate (black line) and average SKNA (aSKNA) from 
Lead I (blue) and Lead II (green) are plotted over time. A total of 8 VT episodes occurred during 1-hour periods of aSKNA. The onsets of VT are indicated by 
red dotted lines, with each red dotted line representing several individual episodes of VT, which could not be distinguished graphically. A red dot indicates 
the onset of aSKNA, which is associated with sinus HR acceleration before the development of VT. There is the latency between SKNA activation and the 
first VT onset (red bar) and deactivation to the last VT episode (blue bar). The large burst lasted 6 minutes (black bar). After VT clustering, smaller aSKNA 
bursts did not induce VT. (B) The data came from a different patient. A total of 11 VT episodes were observed during 2 hours of recording. Similar to A, large 
SKNA bursts preceded VT episodes, and the latency between SKNA onset and VT were 2 minutes and 7 minutes, respectively. There were smaller bursts of 
nerve activities associated with premature ventricular contributions (black arrows).
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single-spike mode by its large amplitudes and durations. Burst detection is an important technique that 
forms the basis of  analyzing SNA recorded with microneurography techniques (34). However, because 
microneurography recordings are usually of  short duration, it is possible to perform manual analyses 
of  the burst activity. The neuECG recordings are much longer; thus, automated methods are needed 
for burst detection. A primary difference between baseline and burst activities is the amplitude. We 
plotted the proportion of  amplitude distribution of  all SKNA recorded from each patient to visualize 
2 groups of  nerve activities: the baseline (nonbursting) nerve activity and the high-amplitude bursting 
activity. These 2 groups of  nerve activity are then fitted with an expectation-maximization method to 
identify 2 Gaussian distributions. From the Gaussian representing the lower amplitude activity, the 
mean plus 3 times SD was used as the threshold amplitude for burst determination in each patient with 
AF. These bursts were then plotted in a binary series graph to determine whether there is an associa-
tion between burst discharges and the onset of  AF.
Arrhythmia clusters. Clustering was defined by an arrhythmic episode followed within 1 minute by the 
spontaneous recurrences of  the same arrhythmia. We defined AF as a sudden onset of  rapid irregular 
atrial activations with irregular ventricular responses. All onset and termination of  the arrhythmia epi-
sodes were spontaneous. IRAF was defined as a reinitiation (recurrence) of  AF within 1 minute after the 
termination of  a prior AF episode (42). Bradycardia was defined as a HR less than 60 bpm. To determine 
the aSKNA and HR before and after termination of  AF, all AF episodes lasting at least 10 seconds and 
separated by ≥10 seconds were identified. Shorter episodes were excluded from the analyses. VT/VF was 
defined as 3 or more consecutive ventricular beats with rates faster than 100 bpm. Similar to IRAF, we 
defined IRVT as a reinitiation of  VT/VF within 1 minute after the termination of  a prior episode. Epi-
sodes of  arrhythmia were considered separate if  there was at least 1 sinus or paced beat in between. We 
defined polymorphic ventricular arrhythmia as a VT/VF episodes with QRS waves varying in amplitude, 
axis, and duration. The monomorphic VT was defined by VT with identical QRS complexes.
HRV analyses. HRV was performed using LabChart-Pro (ADInstruments) 3 minutes before and after the 
onset of  SKNA bursts that preceded arrhythmic episodes. All ectopic beats were excluded from the analyses. 
For time domain analysis, the SD of  NN intervals (SDNN) and the square root of  the mean of  the squares 
of  the successive differences between adjacent NNs (RMSSD) were included. For the frequency domain 
analysis, the total power (TP), very low frequency (VLF) (0–0.04 Hz), low frequency (LF) (0.04–0.15 Hz), 
and high frequency (HF) (0.15–0.45 Hz) components; LF normalized unit (LF nu); HF normalized unit (HF 
nu); and LF-HF ratio were included. LF nu was calculated as LF/ (TP-VLF) × 100. HF nu was calculated 
as HF/(TP-VLF) × 100 (40).
Statistics
Continuous variables were summarized by mean and SDs for the normally distributed data or median (IQR) 
for the nonnormally distributed data. Categorical variables were summarized by frequency and percentage. 
The unpaired, 2-tailed Student’s t test or the Mann-Whitney U test was used to compare continuous mea-
sures and the χ2 test was used for dichotomous variables. The paired, 2-tailed t test or the Wilcoxon signed 
rank test was used within group comparisons. Kolmogorov-Smirnov test was used to check normality of  
continuous variables. The distribution of  the number of  AF onset by 3-hour intervals (0:00 to 2:59, 3:00 
to 5:59, 6:00 to 8:59, 9:00 to 11:59, 12:00 to 14:59, 15:00 to 17:59, 18:00 to 20:59, and 21:00 to 23:59) 
was tested for uniformity by the χ2 goodness-of-fit test. Pair-wise comparison of  the number of  AF onset 
was performed by the exact binomial test with Bonferroni correction. Pearson’s or Spearman’s correlation 
coefficient was used to measure linear correlation between the burst amplitude and the duration of  burst. 
Two-sided P ≤ 0.05 was considered statistically significant.
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